ui.skipToMain
Comercializadora de Servicios Médicos Cubanos, S.A.SMC Salud

For U.S. Patients · Diabetes Complications

Diabetic Foot Ulcer Treatment in Cuba

Heberprot-P growth factor therapy for ulcers that have not healed at home

A concentrated, multidisciplinary program for non-healing diabetic foot ulcers in Havana, built around intralesional Heberprot-P injections, daily debridement, infection control and offloading — with the travel paperwork, English-speaking coordination and home follow-up handled for you.

Cuban wound-care specialist assessing a diabetic foot ulcer for Heberprot-P treatment

Heberprot-P®

Recombinant human growth factor — not FDA-approved, not available in the U.S.

At a glance

What diabetic foot treatment can U.S. patients get in Cuba?

Cuba treats chronic diabetic foot ulcers with Heberprot-P — a recombinant human epidermal growth factor injected into the wound edges — inside an intensive multidisciplinary program in Havana. U.S. patients typically stay two to eight weeks, pay directly (Medicare and U.S. insurance do not cover care in Cuba), and return home with a written plan plus telemedicine follow-up. Heberprot-P is not a cure and no outcome is guaranteed.

Condition
Chronic diabetic foot ulcers, Wagner grade 2–4, unresponsive to standard care
Key therapy
Heberprot-P® intralesional hEGF, three injections per week
Program length
2–8 weeks in Havana, confirmed in your written plan
Location
CIGB-affiliated wound-care facility, Havana
Approach
Daily debridement, infection control, offloading, rehabilitation
Aftercare
Medical report for your U.S. doctor + telemedicine follow-up

Our Comprehensive Approach

Heberprot-P® Growth Factor Therapy

Intralesional recombinant human epidermal growth factor for ulcers that have not responded to standard care

Non-Healing Diabetic Foot Ulcers

Wounds still open after 4+ weeks of conventional dressings, debridement and offloading

Infected Wounds

Culture-guided antibiotics, surgical debridement and daily infection surveillance

Vascular & Neuropathic Assessment

Doppler, ankle-brachial index and neuropathy testing to confirm the wound can heal

Offloading & Total Contact Casting

Professionally managed pressure relief — not left to the patient at home

Limb-Preservation Focus

Healing-first philosophy, with amputation considered only as a last resort

One Coordinated Team

Diabetologist, wound specialist, vascular surgeon, podiatrist and rehabilitation in one program

Glycemic Control

Blood-sugar optimization throughout the program, because healing stalls when glucose is unstable

Built for U.S. Patients

English-speaking coordination, Florida charter flights, travel documentation and telemedicine follow-up

Your Complete Patient Journey

From Arrival to Remote Follow-Up

Every stage of your treatment in Cuba is coordinated for safe healing and lasting recovery — with continued telemedicine support once you return home.

  1. 1

    Arrival in Havana

    Warm airport reception by our multilingual team and comfortable transfer to your accommodation or medical facility.

  2. 2

    Wound & Vascular Assessment

    Comprehensive wound grading (Wagner/University of Texas classification), Doppler vascular study, neurological exam, and glycemic review to confirm Heberprot-P suitability.

  3. 3

    Heberprot-P Intralesional Treatment

    Recombinant growth factor injections delivered into the wound edges three times per week, combined with debridement, specialized dressings, offloading, and infection management.

  4. 4

    Wound Closure & Monitoring

    Ongoing wound measurement, progressive granulation, infection surveillance, and glycemic optimization throughout the treatment cycle.

  5. 5

    Discharge & Footwear Guidance

    Final wound assessment, therapeutic footwear fitting, a detailed home wound-care plan, and a comprehensive medical report for your home physician.

  6. 6

    Follow-up & Telemedicine

    Remote wound monitoring and telemedicine consultations with your Cuban care team, coordinated home wound checks, and rapid support if a new ulcer appears.

Understanding Diabetic Foot Ulcers

Why a wound that won't close needs a different plan

Up to one in four people with diabetes develops a foot ulcer, and a significant share of those ulcers are still open after weeks of outpatient dressings, offloading and antibiotics. In the United States, a non-healing ulcer is the most common path to lower-limb amputation.

Cuba's Center for Genetic Engineering and Biotechnology (CIGB) developed Heberprot-P — a recombinant human epidermal growth factor given by intralesional injection — specifically for this group of wounds. In Havana it is delivered as part of a daily, coordinated program rather than a weekly clinic visit, which is why patients travel for it.

No therapeutic outcome is guaranteed. Every patient is individually evaluated by a multidisciplinary team, and suitability is confirmed through medical review.

What makes the Cuban program different

  • Growth factor access — Heberprot-P is registered in more than 26 countries but is not FDA-approved, so it is unavailable at home.
  • Daily intensity — treatment and review happen every day, not once a week.
  • One team — diabetology, wound care, vascular surgery, podiatry and rehabilitation in a single facility.
  • Healing first — amputation is treated as a last resort, not the default next step.

For U.S. Patients

Our Process, Step by Step

Exactly what happens, who does it, and how long it takes — from your first upload to the follow-up call after you are back in the United States.

  1. 1Day 0

    Send Your Medical Records

    Upload wound photos, ulcer measurements, Doppler/ABI results, HbA1c and your current medications. The wound-care team reviews your case free of charge, with no deposit and no commitment.

  2. 25–10 business days

    Written Plan & Cost Estimate

    Cuba's multidisciplinary wound team grades the ulcer (Wagner / University of Texas) and confirms whether Heberprot-P is appropriate. You receive a written plan with the exact program length and a cost estimate.

  3. 32–3 weeks before travel

    U.S. Travel Authorization & Logistics

    We issue your letter of medical necessity and treatment confirmation, advise on the Cuban Tourist Card or medical visa, book charter flights from Miami, Tampa or Fort Lauderdale, and arrange accommodation and airport reception.

  4. 4Days 1–3 in Havana

    Arrival & Baseline Assessment

    Vascular Doppler, neurological exam, infection screening, glycemic review and wound photography establish your starting point before the first injection.

  5. 52–8 weeks in Havana

    Daily Intensive Treatment

    Heberprot-P intralesional injections three times per week, plus daily debridement, infection management, offloading and rehabilitation — one coordinated team, one facility.

  6. 6Before you fly home

    Report, Footwear & Telemedicine

    A full medical report for your U.S. podiatrist, therapeutic footwear fitting, a home wound-care plan, and scheduled telemedicine follow-up with your Cuban team.

Program length

2–8 weeks in Havana, set by wound response

Payment

Medicare & U.S. insurance don't cover Cuba — self-pay, HSA/FSA may qualify

Support

English-speaking coordinator from first message to follow-up

Paperwork

Passport valid 6+ months; we handle the travel documents

Transparent Pricing

What the Program Costs

A single all-in estimate for U.S. patients — treatment, stay and coordination. Your written plan confirms the exact figure before you commit.

Typical program range

$12,000 – $28,000

USD · depends on ulcer grade and program length

Stays of up to 8 weeks. Travel, accommodation and companion costs are quoted individually in your plan.

What the estimate covers

  • Heberprot-P intralesional treatment45%
  • Wound care & vascular management25%
  • Accommodation & companion20%
  • Diagnostics & Doppler studies10%

Medicare, Medicaid and U.S. private insurance do not cover treatment in Cuba. Payment is made by card through our secure gateway, and HSA/FSA funds may be usable for qualified medical expenses — check with your plan administrator.

Request a Written Estimate

Cuban Biotechnology (CIGB)

Limb-Preservation Focus

Multidisciplinary Team

International Standards

Frequently Asked Questions

Questions from American patients and families

What diabetic foot treatment is available in Cuba that isn't available in the USA?⌄

Cuba offers Heberprot-P, a recombinant human epidermal growth factor (hEGF) developed by the Center for Genetic Engineering and Biotechnology (CIGB) in Havana. It is injected directly into the wound edges to stimulate granulation and healing in chronic diabetic foot ulcers. Heberprot-P is not FDA-approved and is not available in the United States. It is used together with comprehensive wound care, infection management and vascular assessment.

Can U.S. citizens travel to Cuba for diabetic foot treatment?⌄

Yes. U.S. citizens may travel under an approved category, and SMC Salud supplies the letter of medical necessity and treatment confirmation that support the trip. Direct charter flights operate from Miami, Tampa and Fort Lauderdale to Havana, and our coordinators handle the airport reception and accommodation. Passports should be valid for at least six months beyond the travel date.

How does the Cuban program compare with U.S. wound care?⌄

The main differences are access to Heberprot-P and the intensity of care. In the U.S., patients typically receive weekly wound-clinic visits with standard dressings and offloading. In Cuba, patients are treated daily — Heberprot-P injections three times per week, daily debridement, infection management and coordinated multidisciplinary review — in a concentrated program of two to eight weeks.

Is Heberprot-P a cure for diabetic foot ulcers?⌄

No. Heberprot-P is not a cure for diabetes or for diabetic foot ulcers. It is a growth factor therapy intended for chronic ulcers that have not responded to standard treatment. Every patient is evaluated individually by the multidisciplinary team, and suitability depends on ulcer grade, blood supply, infection status and overall health. Outcomes vary.

Can this program help avoid amputation?⌄

Cuba's program is built around wound healing and limb preservation, but no treatment can guarantee that amputation is avoided. Suitability for the program is determined after medical review of the wound, vascular status and infection control. Our team is explicit with U.S. patients about what the program can and cannot do in each individual case.

Does Medicare or U.S. health insurance cover treatment in Cuba?⌄

No. Medicare, Medicaid and U.S. private insurers generally do not cover care received in Cuba, so patients pay directly. HSA/FSA funds may be usable for qualified medical expenses abroad — confirm with your plan administrator. Payment is made by card through our secure gateway, and a written cost estimate is issued before you commit.

How long do U.S. patients need to stay in Havana?⌄

Most programs run between two and eight weeks, depending on ulcer severity and how quickly the wound responds. The written treatment plan you receive after records review states the expected length, and our coordinators arrange accommodation for that period plus any companion travelling with you.

What happens after I return to the United States?⌄

You leave with a comprehensive medical report for your U.S. podiatrist or wound-care team, a home wound-care plan, therapeutic footwear recommendations and imaging or measurements taken during treatment. Scheduled telemedicine consultations with your Cuban team continue after you return home, and our coordinators stay reachable in English.

Diabetic Foot — Treatment & Medication

Treatment Options Available in Cuba

Cuba's Center for Genetic Engineering and Biotechnology (CIGB) developed Heberprot-P®, an intralesional recombinant human epidermal growth factor therapy for complex diabetic foot ulcers that have not responded to conventional wound care. Treatment is combined with comprehensive wound management, vascular assessment, infection control, and glycemic management. Heberprot-P is not a cure, and not every patient will benefit. Treatment suitability is determined after medical evaluation of the ulcer grade, vascular status, and overall health.

Treatment suitability is determined after medical evaluation. No therapeutic outcome is guaranteed, and not every patient will benefit. Each case is reviewed individually by the medical team.

Diabetic Foot — Required Documents

Documents for Medical Evaluation

Providing these documents helps our medical team review your case before you travel. You do not need to send every document to begin — send what you have available.

Medical Diagnosis

Diabetes diagnosis and current status

Ulcer Photographs

Clear images of the wound(s) and surrounding skin

Blood Tests

Recent glucose, HbA1c, and laboratory results

Diabetes Records

Diabetes management history and medications

Previous Treatment Reports

Prior wound care and outcomes

Vascular Reports

Doppler or vascular studies, if available

Send Your Medical Documents

Could This Treatment Be Right for You?

Submit your medical records for review by our medical team. We will assess your case and provide a personalized recommendation. Treatment suitability is determined only after medical evaluation.